A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions : from pathogenesis to treatment
© 2024. The Author(s)..
BACKGROUND: Cutaneous bacillary angiomatosis (cBA) is a vascular proliferative disorder due to Bartonella spp. that mostly affects people living with HIV (PLWH), transplanted patients and those taking immunosuppressive drugs. Since cBA is mostly related to these major immunocompromising conditions (i.e., T-cell count impairment), it is considered rare in relatively immunocompetent patients and could be underdiagnosed in them. Moreover, antimicrobial treatment in this population has not been previously investigated.
METHODS: We searched the databases PubMed, Google Scholar, Scopus, OpenAIRE and ScienceDirect by screening articles whose title included the keywords "bacillary" AND "angiomatosis" and included case reports about patients not suffering from major immunocompromising conditions to provide insights about antibiotic treatments and their duration.
RESULTS: Twenty-two cases of cBA not related to major immunocompromising conditions were retrieved. Antibiotic treatment duration was shorter in patients with single cBA lesion than in patients with multiple lesions, including in most cases macrolides and tetracyclines.
CONCLUSIONS: cBA is an emerging manifestation of Bartonella spp. infection in people not suffering from major immunocompromising conditions. Until evidence-based guidelines are available, molecular tests together with severity and extension of the disease can be useful to personalize the type of treatment and its duration.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
BMC infectious diseases - 24(2024), 1 vom: 08. Apr., Seite 380 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rotundo, Salvatore [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 10.04.2024 Date Revised 11.04.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12879-024-09253-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370791428 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370791428 | ||
003 | DE-627 | ||
005 | 20240411232655.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240409s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-024-09253-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1372.xml |
035 | |a (DE-627)NLM370791428 | ||
035 | |a (NLM)38589795 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rotundo, Salvatore |e verfasserin |4 aut | |
245 | 1 | 2 | |a A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions |b from pathogenesis to treatment |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.04.2024 | ||
500 | |a Date Revised 11.04.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a BACKGROUND: Cutaneous bacillary angiomatosis (cBA) is a vascular proliferative disorder due to Bartonella spp. that mostly affects people living with HIV (PLWH), transplanted patients and those taking immunosuppressive drugs. Since cBA is mostly related to these major immunocompromising conditions (i.e., T-cell count impairment), it is considered rare in relatively immunocompetent patients and could be underdiagnosed in them. Moreover, antimicrobial treatment in this population has not been previously investigated | ||
520 | |a METHODS: We searched the databases PubMed, Google Scholar, Scopus, OpenAIRE and ScienceDirect by screening articles whose title included the keywords "bacillary" AND "angiomatosis" and included case reports about patients not suffering from major immunocompromising conditions to provide insights about antibiotic treatments and their duration | ||
520 | |a RESULTS: Twenty-two cases of cBA not related to major immunocompromising conditions were retrieved. Antibiotic treatment duration was shorter in patients with single cBA lesion than in patients with multiple lesions, including in most cases macrolides and tetracyclines | ||
520 | |a CONCLUSIONS: cBA is an emerging manifestation of Bartonella spp. infection in people not suffering from major immunocompromising conditions. Until evidence-based guidelines are available, molecular tests together with severity and extension of the disease can be useful to personalize the type of treatment and its duration | ||
650 | 4 | |a Systematic Review | |
650 | 4 | |a Bartonella | |
650 | 4 | |a Antibiotic | |
650 | 4 | |a Bacillary angiomatosis | |
650 | 4 | |a Emerging disease | |
650 | 4 | |a One health | |
650 | 4 | |a PCR | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Tassone, Maria Teresa |e verfasserin |4 aut | |
700 | 1 | |a Marascio, Nadia |e verfasserin |4 aut | |
700 | 1 | |a Morrone, Helen Linda |e verfasserin |4 aut | |
700 | 1 | |a Gigliotti, Simona |e verfasserin |4 aut | |
700 | 1 | |a Quirino, Angela |e verfasserin |4 aut | |
700 | 1 | |a Russo, Alessandro |e verfasserin |4 aut | |
700 | 1 | |a Matera, Giovanni |e verfasserin |4 aut | |
700 | 1 | |a Trecarichi, Enrico Maria |e verfasserin |4 aut | |
700 | 1 | |a Torti, Carlo |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d 2001 |g 24(2024), 1 vom: 08. Apr., Seite 380 |w (DE-627)NLM11120089X |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g day:08 |g month:04 |g pages:380 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12879-024-09253-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 1 |b 08 |c 04 |h 380 |